Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 295,728 $ 305,496
Accounts receivable 14,666 9,270
Prepaid expenses and other current assets 25,387 12,952
Total current assets 335,781 327,718
Property, plant and equipment, net 351,132 150,545
Deferred engineering costs 0 110,025
Other non-current assets 45,293 33,518
Total assets 732,206 621,806
Current liabilities:    
Accounts payable 7,802 2,852
Accrued and other liabilities 76,536 85,946
Borrowings 0 0
Total current liabilities 84,338 88,798
Long-term liabilities:    
Borrowings 54,891 53,687
Other non-current liabilities 68,322 61,020
Total long-term liabilities 123,213 114,707
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and 6,123,782 shares outstanding, respectively 61 61
Common stock, $0.01 par value, 800,000,000 authorized: 545,890,311 and 500,453,575 shares outstanding, respectively 5,229 4,774
Additional paid-in capital 1,517,031 1,344,526
Accumulated deficit (997,666) (931,060)
Total stockholders’ equity 524,655 418,301
Total liabilities and stockholders’ equity $ 732,206 $ 621,806